Sensorion joins the Van Lanschot Kempen conference in Amsterdam

Sensorion, a biotechnology company focused on hearing disorders, has confirmed its participation in the Van Lanschot Kempen conference in Amsterdam, from April 2 to 3, 2025. This event brings together several life sciences players and institutional investors.

On April 2, the Sensorion management team will be available for individual meetings. Those interested in meeting with them can submit their request to the email address provided.

This participation allows Sensorion to position itself as a key player in the development of innovative therapies for hearing loss, while strengthening its ties with potential investors.